-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
OrganiGram Holdings Inc. Forecasted to Post Q4 2023 Earnings of ($0.01) Per Share (TSE:OGI)
OrganiGram Holdings Inc. Forecasted to Post Q4 2023 Earnings of ($0.01) Per Share (TSE:OGI)
OrganiGram Holdings Inc. (TSE:OGI – Get Rating) – Atb Cap Markets issued their Q4 2023 earnings per share (EPS) estimates for OrganiGram in a research report issued to clients and investors on Tuesday, November 29th. Atb Cap Markets analyst F. Gomes expects that the company will earn ($0.01) per share for the quarter. The consensus estimate for OrganiGram's current full-year earnings is ($0.07) per share. Atb Cap Markets also issued estimates for OrganiGram's FY2024 earnings at $0.03 EPS.
Get OrganiGram alerts:Separately, Eight Capital dropped their price objective on OrganiGram from C$2.60 to C$1.70 in a research report on Wednesday, August 31st. One analyst has rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and an average price target of C$2.40.
OrganiGram Trading Up 5.0 %
OrganiGram stock opened at C$1.46 on Thursday. The company has a market capitalization of C$458.01 million and a price-to-earnings ratio of -12.37. The company has a current ratio of 4.17, a quick ratio of 2.96 and a debt-to-equity ratio of 1.48. OrganiGram has a 12 month low of C$1.17 and a 12 month high of C$2.69. The business's fifty day simple moving average is C$1.29 and its two-hundred day simple moving average is C$1.35.OrganiGram Company Profile
(Get Rating)
Organigram Holdings Inc, through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co, Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates.
Read More
- Ford Revving Up Production Of EV Power Units At U.K. Plant
- Are the Short Sellers Still Right About Mullen Automotive stock?
- La-Z-Boy Reclines To More Comfortable Levels
- Is The Recovery Rally Here For SoFi?
- Is Apple Going To Rally Into Year End?
Receive News & Ratings for OrganiGram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrganiGram and related companies with MarketBeat.com's FREE daily email newsletter.
OrganiGram Holdings Inc. (TSE:OGI – Get Rating) – Atb Cap Markets issued their Q4 2023 earnings per share (EPS) estimates for OrganiGram in a research report issued to clients and investors on Tuesday, November 29th. Atb Cap Markets analyst F. Gomes expects that the company will earn ($0.01) per share for the quarter. The consensus estimate for OrganiGram's current full-year earnings is ($0.07) per share. Atb Cap Markets also issued estimates for OrganiGram's FY2024 earnings at $0.03 EPS.
OrganiGram Holdings Inc.(多倫多證券交易所股票代碼:OGI-GET Rating)-ATB Cap Markets在11月29日星期二發佈給客户和投資者的一份研究報告中,發佈了他們對OrganiGram 2023年第四季度每股收益(EPS)的估計。ATB Cap Markets分析師F·戈麥斯預計,該公司本季度每股收益將達到0.01美元。對OrganiGram目前全年收益的普遍估計是每股0.07美元。ATB Cap Markets還發布了OrganiGram 2024財年每股收益預期為0.03美元。
Separately, Eight Capital dropped their price objective on OrganiGram from C$2.60 to C$1.70 in a research report on Wednesday, August 31st. One analyst has rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and an average price target of C$2.40.
另外,在8月31日星期三的一份研究報告中,Eight Capital將OrganiGram的目標價從2.60加元下調至1.70加元。一名分析師對該股的評級為賣出,兩名分析師給出了持有評級,四名分析師給出了該公司股票的買入評級。根據MarketBeat的數據,該股的共識評級為持有,平均目標價為2.40加元。
OrganiGram Trading Up 5.0 %
OrganiGram交易上漲5.0%
OrganiGram Company Profile
OrganiGram公司簡介
(Get Rating)
(獲取評級)
Organigram Holdings Inc, through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co, Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates.
OrganiGram Holdings Inc.通過其子公司在加拿大生產和銷售大麻和大麻衍生產品。它提供醫用大麻產品,包括用於平民患者和退伍軍人的大麻花、大麻油和霧化器;成人使用的愛迪生大麻公司、Trail Blazer、Shred、Shred‘Ems、Big Bag O’Buds和Monjour品牌的娛樂用大麻;以及大麻食用產品和濃縮物。
Read More
閲讀更多內容
- Ford Revving Up Production Of EV Power Units At U.K. Plant
- Are the Short Sellers Still Right About Mullen Automotive stock?
- La-Z-Boy Reclines To More Comfortable Levels
- Is The Recovery Rally Here For SoFi?
- Is Apple Going To Rally Into Year End?
- 福特在英國工廠加速生產電動汽車動力裝置
- 賣空者對馬倫汽車股票的看法仍然正確嗎?
- La-Z-Boy傾斜到更舒適的水平
- 復甦集會是為SoFi而來的嗎?
- 蘋果會在年底前大漲嗎?
Receive News & Ratings for OrganiGram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrganiGram and related companies with MarketBeat.com's FREE daily email newsletter.
接受OrganiGram Daily的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對OrganiGram和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧